BioNTech SE

For the period ended Dec 31, 2024. Filed Mar 10, 2025.

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2024 · Filed Mar 10, 2025

BNTX$87.51+1.9%Stored close · as of Nov 6, 2026

Contents

Item 16B. Code of Ethics

We have adopted a Code of Ethics & Business Integrity, or Code of Ethics, which outlines the principles of legal

and ethical business conduct under which we do business. The Code of Ethics applies to all of our Supervisory

Board members, Management Board members, directors of our subsidiaries and employees. The full text of the

Code of Ethics is available on our website at https://www.biontech.de. The information and other content

appearing on our website are not part of this Annual Report and our website address is included in this Annual

Report as an inactive textual reference only. Any amendments or waivers from the provisions of the Code of

Ethics for members of our Supervisory or Management Boards will be made only after approval by our

Supervisory Board and will be disclosed on our website promptly following the date of such amendment or

waiver.

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.